It is designed for high-level protein expression in mammalian cells
Backbone Information
-
Vector Type: Mammalian Expression Vector
-
Expression system: Mammalian
-
Bacterial Resistance(s): Ampicillin
-
Copy number: High
Component Information
-
Promoter1: CMV promoter
-
Enhancer1: CMV enhancer
-
Promoter2: T7
-
Tag: XXXXX
-
Selection marker: XXXXX
-
P2A/IRES: XXXXX
Reference
-
Cappella M, Ciotti C, Cohen-Tannoudji M, Biferi MG. Gene Therapy for ALS-A Perspective. Int J Mol Sci. 2019 Sep 6;20(18):4388. Cappella M, Ciotti C, Cohen-Tannoudji M, Biferi MG. Gene Therapy for ALS-A Perspective. Int J Mol Sci. 2019 Sep 6;20(18):4388.
-
ALS.org (n.d.). Therapies Targeting ALS-Linked Genetic Mutations | The ALS Association. The ALS Association. Retrieved May 22, 2024
-
Ling JP, Pletnikova O, Troncoso JC, Wong PC. TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD. Science.